He has presented and lectured at integrative medical conferences, and is regularly hired by physicians, who consult with him over their complex patient cases
Researchers who study the pancreatic peptide hormone system will recognize glucagon as the metabolic counterweight to insulin, and harnessing it pharmacologically opens therapeutic possibilities that the research community has pursued for decades
In FoB, we found that ATP levels in Gclc -deficient, but not in Gclc -sufficient FoB dropped in a dose-dependent fashion in response to inhibition of glycolysis with 2-deoxy-D-glucose (2-DG) or galactose (Fig
However, these results should be interpreted with caution due to high heterogeneity that was observed among the studies included in this meta-analysis
For venture investors, GLP-1 therapies also represent more than a healthcare trend
17 The increased systemic oxidative stress in disease progression and its association with other oxidative stress-related pathologic conditions were suggested for further studies